Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

CONTX: ContextVision signs partnership agreement for the clinical translation of its quantitative imaging portfolio

CONTXRegulatory press release22.10.2026, 11.00
Discuss
Read the release
ContextVision AB has signed a Master Research Agreement with Linköping
University, Region Östergötland, and the Center for Medical Image Science and
Visualization (CMIV). The agreement will support the clinical validation of
ContextVision's computer aided detection and quantitative ultrasound
solutions.

As part of the collaboration, ContextVision will provide on-site technical
personnel and install its ultrasound research platform at CMIV, complementing
the center's existing MR, CT, and medical imaging diagnostics AI
infrastructure. The collaboration in Linköping provides a broader platform for
ContextVision's programs in quantitative imaging solutions. Prospective
clinical studies will be conducted to evaluate the translation of
software-based diagnostic algorithms into clinical practice, such as the
ongoing development program in Metabolic Dysfunction-Associated Steatotic
Liver Disease (MASLD).

"Developing the technology is one part of the process. We also need strong
clinical evidence that shows how our solutions perform in practice. The
partnership brings together our technology with the research expertise,
clinical experience and imaging infrastructure of Linköping University, Region
Östergötland and CMIV. It gives ContextVision a strong foundation for the
pursued entry into quantitative imaging," says Gerald Pötzsch, CEO of
ContextVision.

"Our mission at CMIV is to advance imaging research and bring it to clinical
practice. The ultrasound research platform from ContextVision complements our
MR and CT programs, as well as allow us to broaden the research topics we can
address. We look forward to working with ContextVision and exploring how
quantitative ultrasound imaging can contribute to future clinical translation
of AI-enabled medical imaging diagnostic solutions," says Anders Persson, MD,
PhD, Director of CMIV and Professor at the Department of Health, Medicine and
Caring Sciences, Linköping University.

About ContextVision
ContextVision is a software company specialized in image analysis and
artificial intelligence. As the global market leader within image enhancement,
we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI
equipment around the world. Our expertise is to develop powerful software
products, based on proprietary technology and artificial intelligence for
image-based applications. Our cutting-edge technology helps clinicians
accurately interpret medical images, a crucial foundation for better diagnosis
and treatment. The company, established in 1983, is based in Sweden with local
representation in the U.S., Japan, China and Korea. ContextVision is listed on
the Oslo Stock Exchange under the ticker CONTX.

About CMIV
CMIV is a multidisciplinary research center initiated in 2002 by Linköping
University, the regional healthcare provider Region Östergötland and the
enterprise medical imaging company Sectra AB. Its mission is to develop
next-generation methods and tools for medical image analysis, interactive 3D
visualization, digital twins, and AI diagnostics, to improve healthcare and
medical research. CMIV is also host to the Analytic Imaging Diagnostic Arena
(AIDA) which is a publicly funded collaboration arena for research and
innovation in medical imaging diagnostics AI, engaging ~50 Swedish partners
from academia, industry, and healthcare in about equal parts. It is also host
to the AIDA Data Hub, which is a data infrastructure supporting AIDA with
services in policy support, data sharing, and secure GPU processing of
sensitive personal data for developing medical imaging diagnostics AI.
ecure GPU processing of\
sensitive personal data for developing medical imaging diagnostics AI.\